Remove Peripheral Arterial Disease Remove Preserved Ejection Fraction Remove Pulmonary
article thumbnail

Top 10: Must-reads from the Month of May

DAIC

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies 4. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) 10.

article thumbnail

Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

European Journal of Heart Failure

The beneficial effects of finerenone in patients with heart failure (HF) and mildly reduced or preserved ejection fraction were consistent, regardless of a history of chronic obstructive pulmonary disease (COPD) status.

article thumbnail

Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does Heart Failure With Supranormal Ejection Fraction Exist? Data From the Swedish Heart Failure Registry

Journal of the American Heart Association

Outcomes (allcause, cardiovascular, and noncardiovascular death; allcause and HF hospitalizations) were assessed by univariable and multivariable Cox regressions with EF modeled as a spline.